Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 52Pancreatic Neoplasms 34Colonic Neoplasms 20Carcinoma, Hepatocellular 20Esophageal Neoplasms 15Neoplasms 14Breast Neoplasms 12Gastrointestinal Neoplasms 11Stomach Neoplasms 10Liver Neoplasms 10Rectal Neoplasms 9Lung Neoplasms 8Head and Neck Neoplasms 7Fibrosis 6Biliary Tract Neoplasms 5Ovarian Neoplasms 4Neoplastic Cells, Circulating 4Neoplasm, Residual 4Neoplasm Metastasis 4Gastrointestinal Stromal Tumors 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Pancreatic Cyst 3Melanoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Cachexia 3Sarcoma 2Prostatic Neoplasms 2Pancreatic Diseases 2

Interventions

bavituximab 1Surveys and Questionnaires 1Spermine Synthase 1Sorafenib 1Sofosbuvir 1Ribavirin 1Phlebotomy 1Liquid Biopsy 1Clinical Protocols 1Blood Specimen Collection 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Blood Specimen Collection × Gastrointestinal × Clear all
NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

Terminated
1,865 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡